Open Access DOI:10.23937/2469-584X/1510075
Covid-19: Gastroenterology Perspectives
Natassia Vianna Bocchese, Noele Gurgel Dávila, Maria Beatriz Maia Rodrigues, Rebecca Renata Lapenda do Monte, Renata Carneiro Melo, Amália Cinthia Meneses Rêgo and Irami Araújo- Filho
Article Type: Review Article | First Published: June 29, 2020
The clinical syndrome caused by SARS-CoV-2 was called COVID-19 and became a pandemic from March 2020. Fever, dry cough, and dyspnoea are the predominant clinical manifestations of the disease. However, symptoms such as diarrhea, nausea, vomiting, and abdominal discomfort can also be found in infected patients. Despite the increased prevalence since the second phase of the recent epidemic in China, scientific evidence on the gastrointestinal manifestations of COVID-19 has received little attentio...
Open Access DOI:10.23937/2469-584X/1510074
COVID-19 and Liver Injury: Hepatology Perspectives
Natassia Vianna Bocchese, Noele Gurgel Dávila, Maria Beatriz Maia Rodrigues, Irami Araújo- Neto, Mariana de Oliveira Costa, Diniz de Meiroz Grillo Barbalho, Amália Cinthia Meneses Rêgo and Irami Araújo-Filho
Article Type: Review Article | First Published: June 27, 2020
SARS-CoV-2, a severe acute respiratory syndrome caused by Coronavirus 2, discovered in 2019 in China, is responsible for the current pandemic declared by the WHO since March 2020. The clinical syndrome caused by Covid-19 has a broad spectrum of severity. The most common clinical manifestations are fever, dry cough, dyspnea, fatigue, and anosmia. The virus binds to receptors for angiotensin-converting enzyme 2 (ECA2) and serine protease TMPRSS2 for protein S initiation, which are expressed not on...
Open Access DOI:10.23937/2469-584X/1510073
Colonization of Lactobacilli among the Fecal Microflora of Healthy Iranian Breast-Fed Infants
Abolfazl Davoodabadi, Mohammad Mehdi Soltan Dallal, Maryam Tajabadi Ebrahimi and Zahra Rajabi
Article Type: Original Research | First Published: May 25, 2020
Lactobacilli are important bacteria among intestinal microflora. They can prevent intestinal colonization by pathogenic bacteria, and used as probiotics. The aim of this study was to investigate the rate Lactobacillus colonization in the fecal of healthy breast-fed infants. Fecal samples were collected from 90 healthy breast-fed infants under 18 months. Lactobacilli were identified by phenotypic and physiological methods. Carbohydrate fermentation patterns were determined using a miniplate metho...
Open Access DOI:10.23937/2469-584X/1510072
A Role for Pre-Polymerized Sucralfate in the Management of Erosive and Non-Erosive Gastroesophageal Reflux Disease
Ricky Wayne McCullough, MD, ScM, FAcadTM
Article Type: Review Article | First Published: March 30, 2020
Clinical outcomes from standard sucralfate do not justify role in the management of erosive and non-erosive gastroesophageal reflux disease. Pre-polymerized sucralfate, sometimes called high potency sucralfate or polymerized cross-linked sucralfate is a new sucralfate formulation recognized by the US FDA in 2005. Positive clinical data from three randomized controlled trials using pre-polymerized sucralfate for GERD and NERD was first reported in 2014 AGA’s Digestive Disease Week (DDW)....
